The European Journal of Health Economics

2002 - 2021

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Track citations for all items by RSS feed
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 22, issue 9, 2021

Pricing vaccines and drugs in Europe: worth differentiating? pp. 1345-1348

Livio Garattini, Anna Padula and Nicholas Freemantle

The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups pp. 1349-1363

V. Lorenzoni, G. Barbieri, F. Saia, F. Meucci, G. L. Martinelli, A. G. Cerillo, S. Berti, P. Candolfi and G. Turchetti

Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis pp. 1365-1370

Ian Grady, Sean Grady and Nailya Chanisheva

Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data pp. 1371-1379

A. Marcellusi, F. S. Mennini, P. Sciattella and G. Favato

Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly pp. 1381-1391

Kailu Wang, Xiaopeng Guo, Siyue Yu, Lu Gao, Zihao Wang, Huijuan Zhu, Bing Xing, Shuyang Zhang and Dong Dong

The effects of health shocks on family status: do financial incentives encourage marriage? pp. 1393-1409

Andree Ehlert

Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana pp. 1411-1425

Isaac Koomson, Abdallah Abdul-Mumuni and Anthony Abbam

Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues pp. 1427-1439

Uğur Pata

Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial pp. 1441-1451

Nathan S. McClure, Mike Paulden, Arto Ohinmaa and Jeffrey A. Johnson

Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population pp. 1453-1466

Petra Baji, Miklos Farkas, Ágota Dobos, Zsombor Zrubka, Levente Kovács, László Gulácsi and Márta Péntek

General population normative data for the EQ-5D-3L in the five largest European economies pp. 1467-1475

Mathieu F. Janssen, A. Simon Pickard and James W. Shaw

A direct method for the identification of patterns of care using administrative databases: the case of breast cancer pp. 1477-1485

Susanna Busco, Andrea Tavilla, Anna Gigli, Tania Lopez, Daniela Pierannunzio, Sandra Mallone, Stefano Guzzinati, Giulia Capodaglio, Francesco Giusti, Catia Angiolini and Silvia Francisci

The costs of celiac disease: a contingent valuation in Switzerland pp. 1487-1505

Laia Soler and Nicolas Borzykowski

Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states pp. 1507-1518

S. A. Lipman, V. T. Reckers-Droog, M. Karimi, M. Jakubczyk and Arthur Attema

The effect of mental and physical health problems on sickness absence pp. 1519-1533

Mark L. Bryan, Andrew M. Bryce and Jennifer Roberts

Volume 22, issue 8, 2021

Structural factors and integrated care interventions: is there a role for economists in the policy debate? pp. 1141-1150

Luke B. Connelly and Gianluca Fiorentini

The economic burden of amyotrophic lateral sclerosis: a systematic review pp. 1151-1166

K. Achtert and L. Kerkemeyer

Complements or substitutes? Associations between volumes of care provided in the community and hospitals pp. 1167-1181

Yiu-Shing Lau, Gintarė Mališauskaite, Nadia Brookes, Shereen Hussein and Matt Sutton

Unpacking the red packets: institution and informal payments in healthcare in China pp. 1183-1194

Ning Liu, Zhuo Chen and Guoxian Bao

Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals pp. 1195-1216

André Madeira, Victor Moutinho and José Fuinhas

The role of health at birth and parental investment in early child development: evidence from the French ELFE cohort pp. 1217-1237

Marion Davin and Emmanuelle Lavaine

On the correlation between outcome indicators and the structure and process indicators used to proxy them in public health care reporting pp. 1239-1251

Benjamin H. Salampessy, France R. M. Portrait, Eric Hijden, Ab Klink and Xander Koolman

Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges pp. 1253-1273

Carlo Federici, Vivian Reckers-Droog, Oriana Ciani, Florian Dams, Bogdan Grigore, Zoltán Kaló, Sándor Kovács, Kosta Shatrov, Werner Brouwer and Michael Drummond

Health state utility values by cancer stage: a systematic literature review pp. 1275-1288

Mir-Masoud Pourrahmat, Ashley Kim, Anuraag R. Kansal, Marg Hux, Divya Pushkarna, Mir Sohail Fazeli and Karen C. Chung

Business cycle and mortality in Spain pp. 1289-1299

María Cervini-Plá and Judit Vall-Castelló

Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms pp. 1301-1309

Koonal K. Shah, Bryan Bennett, Andrew Lenny, Louise Longworth, John E. Brazier, Mark Oppe, A. Simon Pickard and James W. Shaw

Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies pp. 1311-1344

Nikolai Mühlberger, Gaby Sroczynski, Artemisa Gogollari, Beate Jahn, Nora Pashayan, Ewout Steyerberg, Martin Widschwendter and Uwe Siebert

Volume 22, issue 7, 2021

COVID-19: not the time for health economists? A plea for more proactive health economic involvement pp. 1001-1004

J.-Matthias Graf von der Schulenburg

How the COVID-19 pandemic can distort risk adjustment of health plan payment pp. 1005-1016

Richard C. Kleef and Mieke Reuser

The impact of COVID-19 pandemic on insurance demand: the case of China pp. 1017-1024

Xianhang Qian

Can the Covid19 pandemic affect the achievement of the ‘Zero Hunger’ goal? Some preliminary reflections pp. 1025-1038

Donatella Saccone

Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study pp. 1039-1052

Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin and Christelle Gastaldi-Ménager

Economics of mental well-being: a prospective study estimating associated health care costs and sickness benefit transfers in Denmark pp. 1053-1065

Ziggi Ivan Santini, Hannah Becher, Maja Bæksgaard Jørgensen, Michael Davidsen, Line Nielsen, Carsten Hinrichsen, Katrine Rich Madsen, Charlotte Meilstrup, Ai Koyanagi, Sarah Stewart-Brown, David McDaid and Vibeke Koushede

What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB? pp. 1067-1081

Tessa Peasgood, Clara Mukuria, Jill Carlton, Janice Connell, Nancy Devlin, Karen Jones, Rosemary Lovett, Bhash Naidoo, Stacey Rand, Juan Carlos Rejon-Parrilla, Donna Rowen, Aki Tsuchiya and John Brazier

Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China pp. 1083-1093

Wang Pei, Sun Yue, Yang Zhi-Hao, Zhang Ruo-Yu, Wu Bin and Luo Nan

Obesity Kuznets curve and the reality of eco-income ellipsoids (EIE) pp. 1095-1101

Andrew Alola and Festus Bekun

Patient-caregiver agreement and test–retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies pp. 1103-1113

Wenjing Zhou, Anle Shen, Zhihao Yang, Pei Wang, Bin Wu, Michael Herdman and Nan Luo

Assessing the consequences of quarantines during a pandemic pp. 1115-1128

Rikard Forslid and Mathias Herzing

The relationship between renewable energy use and health expenditures in EU countries pp. 1129-1139

Mahmut Unsal Sasmaz, Aysun Karamıklı and Ulas Akkucuk

Volume 22, issue 6, 2021

Something borrowed, something new: measuring hospital performance in the context of value based health care pp. 851-854

Peter Lindgren and Rikard Althin

Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting pp. 855-864

Arnaud Bayle, N. Droin, B. Besse, Z. Zou, Y. Boursin, S. Rissel, E. Solary, L. Lacroix, E. Rouleau, I. Borget and J. Bonastre

Comparison of self-reported and public registered absenteeism among people on long-term sick leave due to musculoskeletal disorders: criterion validity of the iMTA Productivity Cost Questionnaire pp. 865-872

Rikke Munk Killingmo, Anne Therese Tveter, Milada C. Småstuen, Kjersti Storheim and Margreth Grotle

Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data pp. 873-885

Claudia Schulz, Gisela Büchele, Raphael S. Peter, Dietrich Rothenbacher, Christian Brettschneider, Ulrich C. Liener, Clemens Becker, Kilian Rapp and Hans-Helmut König

Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary pp. 887-903

Anikó Bíró and Agnes Szabo-Morvai

The causal impact of sugar taxes on soft drink sales: evidence from France and Hungary pp. 905-915

Christoph F. Kurz and Adriana N. König

Regional medical practice variation in high-cost healthcare services pp. 917-929

Michael Berger and Thomas Czypionka

Using fees to reduce bed-blocking: a game between hospitals and long-term care providers pp. 931-949

Snorre Kverndokk and Hans Olav Melberg

Different levels of care for follow-up of adults with congenital heart disease: a cost analysis scrutinizing the impact on medical costs, hospitalizations, and emergency department visits pp. 951-960

Ruben Willems, Fouke Ombelet, Eva Goossens, Katya De Groote, Werner Budts, Stéphane Moniotte, Michèle de Hosson, Liesbet Van Bulck, Ariane Marelli, Philip Moons, Julie De Backer and Lieven Annemans

Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review pp. 961-975

Kristina Kast, Carl-Philipp Wachter, Oliver Schöffski and Martina Rimmele

Home sweet home: GPs’ response to an increase in the fee size for home visits pp. 977-989

Jamie O’Halloran, Anne Sophie Oxholm, Line Bjørnskov Pedersen and Dorte Gyrd-Hansen

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands pp. 991-999

Marije E. Hagendijk, Simon Schans, Cornelis Boersma, Maarten J. Postma and Simon Pol

Volume 22, issue 5, 2021

The “red herring” after 20 years: ageing and health care expenditures pp. 661-667

Friedrich Breyer and Normann Lorenz

A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland pp. 669-677

Michaela Carla Barbier, Esther Pardo, Cédric Michael Panje, Oliver Gautschi and Judith Eva Lupatsch

Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others pp. 679-697

Sebastian Neumann-Böhme, Stefan A. Lipman, Werner Brouwer and Arthur Attema

How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach pp. 699-709

Shuli Brammli-Greenberg, Ira Yaari, Elad Daniels and Ariella Adijes-Toren

Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses pp. 711-721

Mark Oppe, Daniela Ortín-Sulbarán, Carlos Vila Silván, Anabel Estévez-Carrillo and Juan M. Ramos-Goñi

Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists pp. 723-733

Michael J. Zoratti, A. Simon Pickard, Peep F. M. Stalmeier, Daniel Ollendorf, Andrew Lloyd, Kelvin K W Chan, Don Husereau, John E. Brazier, Murray Krahn, Mitchell Levine, Lehana Thabane and Feng Xie

Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients pp. 735-747

Asrul Akmal Shafie, Irwinder Kaur Chhabra, Jacqueline Hui Yi Wong and Noor Syahireen Mohammed

Are long-term care jobs harmful? Evidence from Germany pp. 749-771

Thomas Rapp, Jérôme Ronchetti and Jonathan Sicsic

Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates pp. 773-788

Samer A. Kharroubi and Yara Beyh

Has the development of cancer biomarkers to guide treatment improved health outcomes? pp. 789-810

Ana Beatriz D′Avó Luís and Mikyung Kelly Seo

Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices pp. 811-831

Jean Spinks, Hong Son Nghiem and Joshua Byrnes

The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach pp. 833-846

Karina Dietermann, Vera Winter, Udo Schneider and Jonas Schreyögg

Correction to: A general framework for classifying costing methods for economic evaluation of health care pp. 847-847

Zuzana Špacírová, David Epstein, Leticia García-Mochón, Joan Rovira, Antonio Olry de Labry Lima and Jaime Espín

Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease pp. 849-849

L. M. Peña-Longobardo, B. Rodríguez-Sánchez, J. Oliva-Moreno, I. Aranda-Reneo and J. López-Bastida

Volume 22, issue 4, 2021

Awaiting the “catharsis” pp. 499-504

John Yfantopoulos

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018 pp. 505-518

Alice Morgan, Sally Hartmanis, Emmanuel Tsochatzis, Philip N. Newsome, Stephen D. Ryder, Rachel Elliott, Lefteris Floros, Richard Hall, Victoria Higgins, George Stanley, Sandrine Cure, Sharad Vasudevan and Lynne Pezzullo

Beyond price: the effects of non-financial barriers on access to drugs and health outcomes pp. 519-529

Lucia Leporatti, Rosella Levaggi and Marcello Montefiori

Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study pp. 531-545

Ina Rissanen, Leena Ala-Mursula, Iiro Nerg and Marko Korhonen

Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia pp. 547-557

Richard Huan Xu, Dong Dong, Nan Luo, Eliza Lai-Yi Wong, Yushan Wu, Siyue Yu, Renchi Yang, Junshuai Liu, Huiqin Yuan and Shuyang Zhang

The economics of alternative payment models for pharmaceuticals pp. 559-569

Jakub P. Hlávka, Jeffrey C. Yu, Dana P. Goldman and Darius N. Lakdawalla

Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations pp. 571-584

Kamolpat Chaiyakittisopon, Oraluck Pattanaprateep, Narisa Ruenroengbun, Tunlanut Sapankaew, Atiporn Ingsathit, Gareth J. Mckay, John Attia and Ammarin Thakkinstian

Economic analysis of open versus laparoscopic versus robotic hepatectomy: a systematic review and meta-analysis pp. 585-604

Ioannis A. Ziogas, Alexandros P. Evangeliou, Konstantinos S. Mylonas, Dimitrios I. Athanasiadis, Panagiotis Cherouveim, David A. Geller, Richard D. Schulick, Sophoclis P. Alexopoulos and Georgios Tsoulfas

The cost of chemotherapy administration: a systematic review and meta-analysis pp. 605-620

Gursharan K. Sohi, Jordan Levy, Victoria Delibasic, Laura E. Davis, Alyson L. Mahar, Elmira Amirazodi, Craig C. Earle, Julie Hallet, Ahmed Hammad, Rajan Shah, Nicole Mittmann and Natalie G. Coburn

Comparison of the three-level and the five-level versions of the EQ-5D pp. 621-628

Anne Simone Juhl Christiansen, Marie Louise Sletskov Møller, Christian Kronborg, Ketil Jørgen Haugan, Lars Køber, Søren Højberg, Axel Brandes, Claus Graff, Søren Zöga Diederichsen, Jonas Bille Nielsen, Derk Krieger, Anders Gaarsdal Holst and Jesper Hastrup Svendsen

Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe pp. 629-642

Mounir Amdaoud, Giuseppe Arcuri and Nadine Levratto

Rising unemployment reduces the demand for healthcare services among people with cardiovascular disease: an Australian cohort study pp. 643-658

Clifford Afoakwah, Hong Son Nghiem, Paul Scuffham and Joshua Byrnes

Correction to: Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort pp. 659-660

Dmitrij Achelrod, Jonas Schreyögg and Tom Stargardt

Volume 22, issue 3, 2021

Accountability for an unhealthy lifestyle pp. 351-355

Daniel M. Campagne

Discounting in economic evaluation of healthcare interventions: what about the risk term? pp. 357-363

Lars Hultkrantz

German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life pp. 365-380

Judith Dams, Elisabeth Huynh, Steffi Riedel-Heller, Margrit Löbner, Christian Brettschneider and Hans-Helmut König

The effect of alcohol tax changes on retail prices: how do on-trade alcohol retailers pass through tax changes to consumers? pp. 381-392

Luke B. Wilson, Robert Pryce, Colin Angus, Rosemary Hiscock, Alan Brennan and Duncan Gillespie

Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer pp. 393-403

Eduard Vrdoljak, Mario Sekerija, Stjepko Plestina, Ingrid Belac Lovasic, Vera Katalinic Jankovic, Livio Garattini, Ana Bobinac and Luka Voncina

Health measures and long-term care use in the European frail population pp. 405-423

Quitterie Roquebert, Jonathan Sicsic and Thomas Rapp

Personalized diabetes management: what do patients with diabetes mellitus prefer? A discrete choice experiment pp. 425-443

Axel C. Mühlbacher, Andrew Sadler and Christin Juhnke

Cost-effectiveness of the latent tuberculosis screening program for migrants in Stockholm Region pp. 445-454

Jad Shedrawy, Charlotte Deogan, Joanna Nederby Öhd, Maria-Pia Hergens, Judith Bruchfeld, Jerker Jonsson, Andrew Siroka and Knut Lönnroth

COVID-19 and income inequality in OECD countries pp. 455-462

John Wildman

Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis pp. 463-471

Yue Zhou, Haishaerjiang Wushouer, Daniel Vuillermin, Xiaodong Guan and Luwen Shi

The impact of social health insurance on rural populations pp. 473-483

Colin Green, Bruce Hollingsworth and Miaoqing Yang

Economic and social cost of epilepsy in Poland: 5-year analysis pp. 485-497

Joanna Jędrzejczak, Beata Majkowska-Zwolińska, Anna Chudzicka-Bator, Iwona Żerda, Magdalena Władysiuk and Brian Godman

Volume 22, issue 2, 2021

More room for telemedicine after COVID-19: lessons for primary care? pp. 183-186

Livio Garattini, Marco Badinella Martini and Michele Zanetti

Revisiting the Swedish alcohol stasis after changes in travelers’ allowances in 2004: petrol prices provide a piece of the puzzle pp. 187-193

Stefan K. Lhachimi

Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition pp. 195-221

Michael Stucki

Sex differences in cigarette brand purchases among adult smokers: results from the DePICT national repeated survey of French adults (2016–2017) pp. 223-228

Fabienne El-Khoury Lesueur, Hugo Torregrossa, Ramchandar Gomajee, Camille Bolze and Maria Melchior

Does NICE influence the adoption and uptake of generics in the UK? pp. 229-242

Victoria Serra-Sastre, Simona Bianchi, Jorge Mestre-Ferrandiz and Phill O’Neill

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events pp. 243-254

Fränce Hardtstock, Zeki Kocaata, Thomas Wilke, Axel Dittmar, Marco Ghiani, Vasily Belozeroff, David J. Harrison, Ulf Maywald and Hans Tesch

Employer survey to estimate the productivity friction period pp. 255-266

Kathleen Manipis, Stephen Goodall, Paul Hanly, Rosalie Viney and Alison Pearce

Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–2015 pp. 267-279

Peipei Chai, Quan Wan and Yohannes Kinfu

Voluntary private health insurance, health-related behaviours and health outcomes: evidence from Russia pp. 281-309

Andrey Aistov, Ekaterina Aleksandrova and Christopher Gerry

COVID-19 and the role of inequality in French regional departments pp. 311-327

Victor Ginsburgh, Glenn Magerman and Ilaria Natali

Does socioeconomic status affect hospital utilization and health outcomes of chronic disease patients? pp. 329-339

Jongsay Yong and Ou Yang

Mapping MacNew Heart Disease Quality of Life Questionnaire onto country-specific EQ-5D-5L utility scores: a comparison of traditional regression models with a machine learning technique pp. 341-350

Lan Gao, Wei Luo, Utsana Tonmukayakul, Marj Moodie and Gang Chen

Volume 22, issue 1, 2021

Do European pharmacists really have to trespass on medicine? pp. 1-4

Livio Garattini, Anna Padula and Nicholas Freemantle

‘Relative Consent’ or ‘Presumed Consent’? Organ donation attitudes and behaviour pp. 5-16

Joan Costa-Font, Caroline Rudisill and Maximilian Salcher-Konrad

Increasing respondent engagement in composite time trade-off tasks by imposing three minimum trade-offs to improve data quality pp. 17-33

Ruixuan Jiang, Thomas Kohlmann, Todd A. Lee, Axel Mühlbacher, James Shaw, Surrey Walton and A. Simon Pickard

Very high and low residual spenders in private health insurance markets: Germany, The Netherlands and the U.S. Marketplaces pp. 35-50

Thomas G. McGuire, Sonja Schillo and Richard C. Kleef

A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England pp. 51-73

Nasuh C. Buyukkaramikli, Peter Wigfield and Men Thi Hoang

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands pp. 75-88

Job F. H. Eijsink, Mohamed N. M. T. Al Khayat, Cornelis Boersma, Peter G. J. Horst, Jan C. Wilschut and Maarten J. Postma

A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiforme pp. 89-100

Martin Connock, Peter Auguste and Xavier Armoiry

Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany? pp. 101-114

Clara Pott, Tom Stargardt, Udo Schneider and Simon Frey

Accreditation as a quality-improving policy tool: family planning, maternal health, and child health in Egypt pp. 115-139

Amira El-Shal, Patricia Cubi-Molla and Mireia Jofre-Bonet

Multi-layer health insurance coverage, medical services use and health in a Universal National Health System, the case of Portugal pp. 141-153

Aida Isabel Tavares and Inês Marques

The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data pp. 155-168

Lluc Puig-Codina, Jaime Pinilla and Jaume Puig-Junoy

Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease pp. 169-180

Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb, Mats Remberger and Jonas Mattsson

Correction to: Healthcare expenditure and carbon footprint in the USA: evidence from hidden cointegration approach pp. 181-181

Murat Gündüz